Meta analysis on the efficacy of pharmacotherapy versus placebo on anorexia nervosa

Journal of Eating Disorders

Volumn 2, Issue 1, 2014, Pages

  de Vos, Jasmijn ^a   Houtzager, Laura ^a,b   Katsaragaki, Georgia ^a   van de Berg, Elske ^a   Cuijpers, Pim ^c   Dekker, Jack ^a  

^a Arkin Mental Health Institute   (Netherlands)

^b De Viersprong Mental Health Institute   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Anorexia nervosa; Meta analysis; Pharmacotherapy; Placebo; Treatment

Indexed keywords

EID: 84925306899     PISSN: None     EISSN: 20502974     Source Type: Journal    
DOI: 10.1186/s40337-014-0027-x     Document Type: Article

References (36)

1. American Psychiatric Association: American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006. Arlington, VA, USA: American Psychiatric Pub; 2006
2. Hudson JI, Hiripi E, Pope HG Jr, Kessler RC: The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007, 61:348-358
3. Attia E, Schroeder L: Pharmacologic treatment of anorexia nervosa: where do we go from here? Int J Eat Disord 2005, 37(Suppl):S60-S63
4. Claudino AM, Silvade Lima M, Hay PPJ, Bacalthcuk J, Schmidt UUS, Treasure J: Antipsychotic Drugs for Anorexia Nervosa (Protocol). England: The Cochrane Library; 2009
5. Mondraty N, Birmingham CL, Touyz S, Sundakov V, Chapman L, Beumont P: Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australas Psychiatry 2005, 13:72-75
6. Bosanac P, Norman T, Burrows G, Beumont P: Serotonergic and dopaminergic systems in anorexia nervosa: a role for atypical antipsychotics? Aust N Z J Psychiatry 2005, 39:146-153
7. Mitchell JE, Steffen K, Cook MT, Roerig J: Pharmacologic and psychotherapeutic treatment of anorexia nervosa. Womens Health (Lond Engl) 2005, 1:115-123
8. Agras WS, Robinson AH: Forty years of progress in the treatment of the eating disorders. Nord J Psychiatry 2008, 62(Suppl 47):19-24
9. Kishi T, Kafantaris V, Sunday S, Sheridan EM, Correll CU: Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis. J Clin Psychiatry 2012, 73:e757-e766
10. Lebow J, Sim LA, Erwin PJ, Murad MH: The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a systematic review and meta-analysis. Int J Eat Disord 2012, 46:332-339
11. Sim LA, McGovern L, Elamin MB, Swiglo BA, Erwin PJ, Montori VM: Effect on bone health of estrogen preparations in premenopausal women with anorexia nervosa: a systematic review and meta-analyses. Int J Eat Disord 2010, 43:218-225
12. Powers PS, Santana C: Available pharmacological treatments for anorexia nervosa. Expert Opin Pharmacother 2004, 5:2287-2292
13. Lipsey MW, Wilson DB: The efficacy of psychological, educational, and behavioral treatment. Confirmation from meta-analysis. Am Psychol 1993, 48:1181-1209
14. Duval S, Tweedie R: Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463
15. Higgins JTP, Green SE: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. England: The Cochrane Collaboration; 2009
16. Borenstein M, Hedges LVHJPT, Rothstein HR: Introduction to Meta-Analysis. Chichester: Wiley; 2009
17. Attia E, Haiman C, Walsh BT, Flater SR: Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry 1998, 155:548-551
18. Attia E, Kaplan AS, Walsh BT, Gershkovich M, Yilmaz Z, Musante D, Wang Y: Olanzapine versus placebo for out-patients with anorexia nervosa. Psychol Med 2011, 41:2177-2182
19. Bissada H, Tasca GA, Barber AM, Bradwejn J: Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 2008, 165:1281-1288
20. Brambilla F, Monteleone P, Maj M: Olanzapine-induced weight gain in anorexia nervosa: involvement of leptin and ghrelin secretion? Psychoneuroendocrinology 2007, 32:402-406
21. Brambilla F, Garcia CS, Fassino S, Daga GA, Favaro A, Santonastaso P, Ramaciotti C, Bondi E, Mellado C, Borriello R, Monteleone P: Olanzapine therapy in anorexia nervosa: psychobiological effects. Int Clin Psychopharmacol 2007, 22:197-204
22. Divasta AD, Feldman HA, Giancaterino C, Rosen CJ, LeboffMS, Gordon CM: The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism 2012, 61:1010-1020
23. Fazeli PK, Lawson EA, Prabhakaran R, Miller KK, Donoho DA, Clemmons DR, Herzog DB, Misra M, Klibanski A: Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2010, 95:4889-4897
24. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A: Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 1996, 81:3864-3870
25. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A: Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002, 87:2883-2891
26. Halmi KA, Eckert E, LaDu TJ, Cohen J: Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 1986, 43:177-181
27. Hill K, Bucuvalas J, McClain C, Kryscio R, Martini RT, Alfaro MP, Maloney M: Pilot study of growth hormone administration during the refeeding of malnourished anorexia nervosa patients. J Child Adolesc Psychopharmacol 2000, 10:3-8
28. Kafantaris V, Leigh E, Hertz S, Berest A, Schebendach J, Sterling WM, Saito E, Sunday S, Higdon C, Gollden NH, Malhotra AK: A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. J Child Adolesc Psychopharmacol 2011, 21:207-212
29. Lacey JH, Crisp AH: Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J 1980, 56(Suppl 1):79-85
30. Miller KK, Meenaghan E, Lawson EA, Misra M, Gleysteen S, Schoenfeld D, Herzog D, Klibanski A: Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2011, 96:2081-2088
31. Misra M, Katzman D, Miller KK, Mendes N, Snelgrove D, Russell M, Goldstein MA, Ebrahimi S, Clauss L, Weigel T, Mickley D, Schoenfeld DA, Herzog DB, Klibanski A: Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 2011, 26:2430-2438
32. Strokosch GR, Friedman AJ, Wu SC, Kamin M: Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebocontrolled study. J Adolesc Health 2006, 39:819-827
33. Vandereycken W: Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled study with sulpiride. Br J Psychiatry 1984, 144:288-292
34. Walsh BT, Kaplan AS, Attia E, Olmsted M, Parides M, Carter JC, Pike KM, Devlin MJ, Woodside B, Roberto CA, Rockert W: Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA 2006, 295:2605-2612
35. Walsh BT, Devlin MJ: Eating disorders: progress and problems. Science 1998, 280:1387-1390
36. Brody H: The placebo response. J Fam Pract 2000, 49:649-654